OpenURL Connection Search

Select item for more details and to access through your institution.

Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11623-9
By:
- Cohen, Taylor S.;
- Kelly, Elizabeth J.;
- Nylander, Sven;
- Bansal, Himanshu;
- Jepson, Brett M.;
- Bhuyan, Prakash;
- Sobieszczyk, Magdalena E.;
- Falsey, Ann R.
Publication type:
Article
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated.
Published in:
Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1062067
By:
- Maaske, Jill;
- Sproule, Stephanie;
- Falsey, Ann R.;
- Sobieszczyk, Magdalena E.;
- Luetkemeyer, Anne F.;
- Paulsen, Grant C.;
- Riddler, Sharon;
- Robb, Merlin L.;
- Rolle, Charlotte-Paige;
- Sha, Beverly E.;
- Tina Tong;
- Ahani, Bahar;
- Aksyuk, Anastasia A.;
- Bansa, Himanshu;
- Egan, Timothy;
- Jepson, Brett;
- Padilla, Marcelino;
- Pate, Nirmeshkumar;
- Shoemaker, Kathryn;
- Stanley, Ann Marie
Publication type:
Article
Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults.
Published in:
NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00287-7
By:
- Oshansky, Christine M.;
- King, James;
- Lu, Di;
- Zhou, James;
- Pavetto, Corrina;
- Horwith, Gary;
- Biscardi, Karen;
- Nguyen, Bai;
- Treanor, John J.;
- Chen, Li-Mei;
- Jepson, Brett;
- BPI17002 Study Coordination Team;
- Colfer, Chad;
- Hylton, Penny;
- Little, James;
- O'Hara, Michael;
- Tresnjak-Smith, Silvija;
- Walker, Robert;
- Yeh, Bai;
- Bright, Rick A.
Publication type:
Article
Alpha‐1 antitrypsin treatment of new‐onset type 1 diabetes: An open‐label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.
Published in:
Pediatric Diabetes, 2018, v. 19, n. 5, p. 945, doi. 10.1111/pedi.12660
By:
- Weir, Gordon C.;
- Ehlers, Mario R.;
- Harris, Kristina M.;
- Kanaparthi, Sai;
- Long, Alice;
- Phippard, Deborah;
- Weiner, Lia J.;
- Jepson, Brett;
- McNamara, James G.;
- Koulmanda, Maria;
- Strom, Terry B.;
- on behalf of the ITN RETAIN Study Team
Publication type:
Article
Systemic Bioavailability of Sublingual Atropine Ophthalmic Solution: a Phase I Study in Healthy Volunteers with Implications for Use as a Contingency Medical Countermeasure.
Published in:
Journal of Medical Toxicology, 2022, v. 18, n. 3, p. 187, doi. 10.1007/s13181-021-00873-0
By:
- Schwartz, Michael D.;
- Raulli, Robert;
- Laney, Judith W.;
- Coley, William;
- Walker, Robert;
- O'Rourke, Anna W.;
- Raine, Kathryn;
- Horwith, Gary;
- Gao, Yonghong;
- Eisnor, Derek L.;
- Lu, Di;
- Wolling, Brenda;
- David, Gloria;
- Johnson, Keli;
- Barry, William T.;
- Chang, Jamie;
- Jepson, Brett;
- Fein, Melanie
Publication type:
Article

Found: 5

Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination.

Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated.

Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults.

Alpha‐1 antitrypsin treatment of new‐onset type 1 diabetes: An open‐label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.

Systemic Bioavailability of Sublingual Atropine Ophthalmic Solution: a Phase I Study in Healthy Volunteers with Implications for Use as a Contingency Medical Countermeasure.